Riskpilot← Back to searchSign inGet full accessHEART2START ApS
APSActiveCVR 32446329Smedevej 38CWholesale of pharmaceutical and medical goods · NACE 4646Est. 20092 employees
Revenue 2024
DKK 591K
-56% vs 2023
EBITDA margin
-116.5%
-3100% vs 2023
Equity ratio
2.9%
Financial strength
Net profit 2024
DKK -578K
-3655% vs 2023
| Revenue | DKK 591K | -56% |
| EBITDA | DKK -688K | -3100% |
| Net profit | DKK -578K | -3655% |
| Total assets | DKK 1,3M | +7% |
| Equity | DKK 38K | -94% |
| Employees | 2 | — |
Legal name
HEART2START ApS
CVR number
32446329
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. september 2009
Share capital
DKK 125.000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren alene
Company purpose
Selskabets formål er at drive produktion, undervisning og salgsvirksomhed indenfor personlig sikkerhed.
Address
Smedevej 38C
Phone
+4521782896
Email
kry@heart2start.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1.728 | 1.593 | 1.327 | 1.329 | 591 |
| Staff expenses | -1.647 | -1.510 | -1.302 | -1.306 | -1.279 |
| EBITDA | 81 | 83 | 25 | 23 | -688 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | 81 | 83 | 25 | 23 | -688 |
| Net financials | -1 | -4 | -1 | -1 | -53 |
| Profit before tax | 80 | 79 | 23 | 22 | -741 |
| Tax | 18 | 17 | 5 | 6 | -163 |
| Net profit | 62 | 62 | 19 | 16 | -578 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1.780 | 1.531 | 1.152 | 1.221 | 1.303 |
| Equity | 518 | 580 | 599 | 616 | 38 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.262 | 951 | 553 | 605 | 1.265 |
| Total debt | 1.262 | 951 | 553 | 605 | 1.265 |
EBITDA margin
-116.5%
This company
15.8%
Market median
-837% vs market
20202024
Equity ratio
2.9%
This company
38.2%
Market median
-92% vs market
20202024
Return on equity
-1538.5%
This company
18.4%
Market median
-8461% vs market
20202024
Net profit margin
-97.9%
This company
8.1%
Market median
-1309% vs market
20202024
Asset turnover
0.45×
This company
1.12×
Market median
-60% vs market
20202024
Debt / equity
33.67×
This company
0.62×
Market median
-5331% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KF Founder | Founder | 2009 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50–66.65% | 50–66.65% | 2009 | |
| Company | 25–33.32% | 25–33.32% | 2009 | |
| Individual | 5–9.99% | 5–9.99% | 2022 | |
| Individual | 5–9.99% | 5–9.99% | 2009 | |
| Company | 5–9.99% | 5–9.99% | 2019 | |
| Company | 33.33–49.99% | 33.33% | 2011 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
FAMILIESELSKABET FER ApS
HEART2START ApS Board members of HEART2START ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kamilla Funch | Founder | 0 companies |